Literature DB >> 8156503

Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma.

J A Bridge1, A Dembinski, J DeBoer, J Travis, J R Neff.   

Abstract

BACKGROUND: The pathogenesis of osteofibrous dysplasia, a rare fibroosseous lesion occurring almost exclusively in the tibia of children younger than 10 years of age, is not known. One theory is that osteofibrous dysplasia results from excessive resorption of bone with fibrous repair of the defect. Alternatively, osteofibrous dysplasia has been considered a congenital lesion or a variant of fibrous dysplasia. It has been hypothesized that osteofibrous dysplasia is a secondary reactive process to adamantinoma. Cytogenetic analysis is one form of investigation that has been instrumental in determining the origin of many disorders.
METHODS: Short-term cultures of two separate osteofibrous dysplasia specimens (approximately 1 year apart) from the tibia of an 11-year-old boy and 2 separate specimens (approximately 2 years apart) from the tibia of a 16-year-old boy were cytogenetically examined using standard procedures. Additionally, fluorescence in situ hybridization (FISH) studies were performed on uncultured cells of both specimens of the first patient using an alpha-satellite probe for chromosome 12.
RESULTS: Cytogenetic and FISH analysis revealed trisomy 12 in both specimens of the first patient. Trisomy for chromosomes 7, 8, and 22 was seen in both specimens of the second patient.
CONCLUSIONS: Osteofibrous dysplasia has not previously been subjected to cytogenetic analysis. Trisomy 7 and 12, however, have been reported in a clonally aberrant adamantinoma, potentially providing further support for a relationship between these two lesions. Most importantly, these findings demonstrate a clonal and possibly neoplastic origin for osteofibrous dysplasia of long bone.

Entities:  

Mesh:

Year:  1994        PMID: 8156503     DOI: 10.1002/1097-0142(19940315)73:6<1746::aid-cncr2820730632>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma.

Authors:  Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2003-03-22       Impact factor: 2.199

Review 2.  Bilateral osteofibrous dysplasia: a report of two cases and review of the literature.

Authors:  U K Sunkara; P D Sponseller; N Hadley Miller; E F McCarthy
Journal:  Iowa Orthop J       Date:  1997

3.  p63 expression in adamantinoma.

Authors:  Brendan C Dickson; Yair Gortzak; Robert S Bell; Peter C Ferguson; David J C Howarth; Jay S Wunder; Rita A Kandel
Journal:  Virchows Arch       Date:  2011-06-15       Impact factor: 4.064

Review 4.  Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma.

Authors:  M Kanamori; C R Antonescu; M Scott; R S Bridge; J R Neff; S S Spanier; M T Scarborough; G Vergara; H G Rosenthal; J A Bridge
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

5.  Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone.

Authors:  J A Bridge; S J Swarts; C Buresh; M Nelson; J M Degenhardt; S Spanier; G Maale; A Meloni; J C Lynch; J R Neff
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Primary adamantinoma of the rib. Unusual presentation for a bone neoplasm of uncertain origin.

Authors:  Sergio Piña-Oviedo; Luis Del Valle; Rafael Padilla-Longoria; Hilda Mendoza-Ramón; Carlos Ortiz-Hidalgo
Journal:  Pathol Oncol Res       Date:  2008-04-12       Impact factor: 3.201

7.  Differentiated adamantinoma of the fibula: a rhabdoid variant.

Authors:  C Povýsil; A Kohout; K Urban; M Horák
Journal:  Skeletal Radiol       Date:  2004-03-04       Impact factor: 2.199

8.  DNA aberrations in the epithelial cell component of adamantinoma of long bones.

Authors:  H M Hazelbag; G J Fleuren; C J Cornelisse; L J van den Broek; A H Taminiau; P C Hogendoorn
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

9.  Treatment of osteofibrous dysplasia and associated lesions.

Authors:  Soo Bong Hahn; Sung Hun Kim; Nam Hoon Cho; Chul Jun Choi; Bom Soo Kim; Ho Jung Kang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

10.  Adamantinoma: a clinicopathological review and update.

Authors:  Deepali Jain; Vijay K Jain; Rakesh K Vasishta; Prabhat Ranjan; Yashwant Kumar
Journal:  Diagn Pathol       Date:  2008-02-15       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.